MedLife IV (IFC-37926)

  • Romania
Where the impacts of the investment may be experienced.
Financial Institutions
  • International Finance Corporation (IFC)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Project Status
Bank Risk Rating
Risk rating varies among banks and may refer only to the particular investment and not to the risk for the project as a whole. Projects marked 'U' have an 'Unknown' risk rating at the time of disclosure.
Voting Date
Aug 23, 2016
The estimate day the bank will vote on a proposed investment. The decision dates may change, so review updated project documents or contact the EWS team.
The holder of the loan, grant, or other investment.
  • Industry and Trade
The service or industry focus of the investment. A project can have several sectors.
Investment Type(s)
The categories of the bank investment: loan, grant, etc.
Investment Amount (USD)
$ 11.11 million
Value listed on project documents at time of disclosure. If necessary, converted to USD$. Please review updated project documents for more information.
Project Cost (USD)
$ 35.91 million
Value listed on project documents at time of disclosure. If necessary, converted to USD$. Please see updated project documentation for more information.
Primary Source

Original disclosure @ IFC website

Updated in EWS Aug 29, 2017

Disclosed by Bank Mar 18, 2016

Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description
The IFC investment consists of an A-loan of up to EUR13.6 million to MedLife to support its EUR55million 2015-17 expansion plan (the "project") in Romania which includes; (i) expanding operations within Romania, including new acquisitions in Bucharest, Craiova, Timisoara and Oradea; and (ii) broadening its health services offering both by acquisition and by new asset construction. MedLife is a health care provider chain in Romania with 13 multidisciplinary clinics, 10 monodisciplinary clinics, 8 medical laboratories, 6 multi and monodisciplinary hospitals, 3 maternity hospitals and 11 pharmacies located in several cities in Romania, but mainly in Romania's capital, Bucharest.
Investment Description
The Marcu family, with extensive experience in the health care sector in Romania, founded MedLife and remain the Company’s controlling shareholders. All three family members - Dr. Mihaela Marcu Cristescu, Head of Pediatrics Department; Mr. Mihail Marcu, Chairman of the Board and Dr. Nicolae Marcu, Chief Executive Officer, remain involved and committed to the Company. Together, they control 51% of the Company’s shares. Value4Capital is an independent private equity firm owns 36.25% stake in MedLife and IFC owns the remaining 12.75% stake in the Company.

Contact Information
ACCOUNTABILITY MECHANISM OF IFC The Compliance Advisor Ombudsman (CAO) is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an IFC or MIGA- financed project. If you submit a complaint to the CAO, they may assist you in resolving a dispute with the company and/or investigate to assess whether the IFC is following its own policies and procedures for preventing harm to people or the environment. If you want to submit a complaint electronically, you can email the CAO at You can learn more about the CAO and how to file a complaint at